NovaBridge Biosciences (NBP) Depreciation & Amortization (CF) (2019 - 2025)
NovaBridge Biosciences (NBP) reported Depreciation & Amortization (CF) of $15000.0 for Q4 2025, down 31.82% year-over-year from $22000.0 in Q4 2024, and down 11.76% quarter-over-quarter from $17000.0 in Q3 2025.
NovaBridge Biosciences (NBP) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $15000.0 in Q4 2025.
- Depreciation & Amortization (CF) for Q4 2025 came in at $15000.0, down 31.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $32000.0 (down 23.81% YoY), and the FY2025 annual result was $68000.0, down 77.33% from the prior year.
- Depreciation & Amortization (CF) declined to $15000.0 in Q4 2025 per NBP's latest filing, from $17000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $22000.0 in Q4 2024 and troughed at $15000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 429,663.65 |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15,000.00 |
| Dec 31, 2025 | 15,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Dec 31, 2020 | 755,220.95 |
| Dec 31, 2020 | 755,220.95 |
| Sep 30, 2020 | 382,291.49 |
| Sep 30, 2020 | 382,291.49 |
| Dec 31, 2019 | 425,074.79 |
| Dec 31, 2019 | 425,074.79 |